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Validation of a screening tool to identify older
children living with HIV in primary care facilities
in high HIV prevalence settings
Tsitsi Bandasona, Grace McHugha, Ethel Dauyaa, Stanley Mungofab,
Shungu M. Munyatia, Helen A. Weissc, Hilda Mujurud,
Katharina Kranzerc and Rashida A. Ferranda,e
Objective: We previously proposed a simple tool consisting of five items to screen for
risk of HIV infection in adolescents (10–19 years) in Zimbabwe. The objective of this
study is to validate the performance of this screening tool in children aged 6–15 years
attending primary healthcare facilities in Zimbabwe.
Methods: Children who had not been previously tested for HIV underwent testing with
caregiver consent. The screening tool was modified to include four of the original five
items to be appropriate for the younger age range, and was administered. A receiver
operator characteristic analysis was conducted to determine a suitable cut-off score.
The sensitivity, specificity and predictive value of the modified tool were assessed
against the HIV test result.
Results: A total of 9568 children, median age 9 (interquartile, IQR: 7–11) years and
4971 (52%) men, underwent HIV testing. HIV prevalence was 4.7% (95% confidence
interval, CI:4.2–5.1%) and increased from 1.4% among those scoring zero on the tool
to 63.6% among those scoring four (P<0.001). Using a score of not less than one as the
cut-off for HIV testing, the tool had a sensitivity of 80.4% (95% CI:76.5–84.0%),
specificity of 66.3% (95% CI:65.3–67.2%), positive predictive value of 10.4% and a
negative predictive value of 98.6%. The number needed to screen to identify one child
living with HIV would drop from 22 to 10 if this screening tool was used.
Conclusion: The screening tool is a simple and sensitive method to identify children
living with HIV in this setting. It can be used by lay healthcare workers and help
prioritize limited resources.
Copyright  2016 Wolters Kluwer Health, Inc. All rights reserved.
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Introduction
HIV testing is the first step towards accessing HIV
prevention and care services. The coverage of anti-
retroviral therapy (ART) is disproportionately lower in
children (30%) than in adults (43%) in sub-Saharan Africa,
the key reason for this disparity being the lowHIV testing
rates in children [1]. Delayed diagnosis and treatment
are associated with poor outcomes, and adolescents are
the only age-group in which HIV-related deaths are
aBiomedical Research and Training Institute, Harare, bHarare City Health, Harare, Zimbabwe, cDepartment of Infectious Disease
Epidemiology, London School of Hygiene and Tropical Medicine, London, UK, dDepartment of Paediatrics, University of
Zimbabwe, Harare, Zimbabwe, and eClinical Research Department, London School of Hygiene and Tropical Medicine, London,
UK.
Correspondence to Tsitsi Bandason, Biomedical Research and Training Institute, P.O. Box CY1753, Causeway, Harare,
Zimbabwe.
Tel: +263 4 745583; e-mail: tbandason@brti.co.zw
Received: 25 August 2015; revised: 8 October 2015; accepted: 21 October 2015.
DOI:10.1097/QAD.0000000000000959
ISSN 0269-9370 Copyright Q 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an open access article distributed under the
Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. 779
 Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
continuing to increase, predominantly as a result of
delayed diagnosis and institution of ARTamong children
[2,3].
The World Health Organization (WHO) recommends
provider-initiated HIV testing and counselling (PITC)
for all individuals attending any healthcare facility in high
HIV prevalence settings [4]. In recognition of the
substantial gap in HIV testing in older children, the
WHO developed specific HIV testing and counselling
guidelines for adolescents in 2013, recommending PITC
for adolescents in highHIV prevalence settings [5]. This is
important as optimal implementation and universal
coverage of prevention of mother-to-child transmission
programmes in many highHIV prevalence settings has yet
to be achieved [6–8]. Moreover, coverage of HIV testing
in infancy remains poor with almost half of the high
priority countries reporting coverage of less than 20% [9].
Only four countries – Namibia, South Africa, Swaziland
and Zambia – provide early infant diagnosis to more than
50% of the children born to women living with HIV [9–
11]. Thus with the current levels of programme
performance a significant number of children living with
HIVwill reach older childhood without being diagnosed.
Whereas PITC for adolescents and children is recom-
mended, the extent to which it is implemented in
primary healthcare facilities is variable [12]. The few
studies that have systematically reported on PITC
in children and adolescents show low rates of HIV
testing being offered by healthcare providers to
children [13,14]. Vertically acquired HIV is likely to
be responsible for the majority of symptomatic HIV
infections in this age group in Southern Africa [15–17].
The lack of implementation of PITC in this age-group
may be explained by a combination of factors such as
limited awareness of the burden of vertically acquired
HIV in older children, resulting in healthcare workers
selectively offering HIV testing to those presenting with
symptoms suggestive of HIV rather than to all children.
Many of the long-term survivors of mother-to-child
HIV transmission present to primary healthcare services
with conditions such as chronic upper respiratory tract
and skin infections that are also common among
children who are not living with HIV [17,18]. HIV
testing is thus offered when children present with the
typical HIV-associated manifestations when HIV infec-
tion is at a more advanced stage [19]. Failure to consider
long-term survival following vertical HIV infection
therefore results in missed opportunities for timely
diagnosis, and increases the risk of mortality and
development of severe, irreversible long-term compli-
cations [20]. In addition, due to verticality of
programmes, donor-driven priorities and workforce
and logistic constraints (such as limited supply of HIV
testing kits), HIV testing is prioritized in specific groups
such as individuals diagnosed with tuberculosis and
pregnant women [13,14].
Given resource constraints and the relatively low
prevalence of HIV among older children and adolescents
compared with adults, an initial screening tool to identify
those at risk of being HIV-infected and then offering
testing to those who screen positive could reduce the
numbers that would need to undergo HIV testing and
increase the yield. Such a screening tool would require
sufficient sensitivity and specificity and be relatively cheap
to administer.
We previously developed a simple screening tool for
adolescence aged 10–19 years to identify those at risk of
being HIV-infected in primary healthcare clinics (PHCs)
in Harare, Zimbabwe. Fourteen socio-demographic and
clinical variables defined a priori were considered in the
development of the screening tool. The final screening
tool consisted of five items, and using a cut-point of two
provided sensitivity of 74% and specificity of 80% [21].
The screening tool can be administered by a lay healthcare
worker, with an affirmative response to any two or more
items prompting an offer of HIV testing. This study aimed
to validate a modified screening tool in a large
independent population, and to assess its performance
under routine conditions in seven PHCs in Harare,
Zimbabwe.
Methods
The study was conducted from January 2013 to
December 2014 in seven PHCs in south-western Harare,
Zimbabwe, as described previously [13]. In brief, all
children aged 6–15 years who attended a PHC for any
reason were offered HIV testing. HIV testing was carried
out with guardian consent and child assent, as per national
guidelines [22]. Those who had a documented HIV test
result from the past 6 months, were known to be HIV-
positive, were attending without a caregiver (unless an
emancipated minor), required immediate hospitalization
or were moribund were not offered HIV testing and were
excluded from this study. The caregiver or child was asked
to respond to four screening items asked by lay healthcare
assistants regardless of whether the child underwent HIV
testing and regardless of the HIV test result.
The following screening items were used:
(1) Has the child been admitted to hospital before?
(2) Does the child have recurring skin problems?
(3) Are one or both parents of the child deceased?
(4) Has the child had poor health in the last 3 months?
The original screening tool included a fifth item
enquiring about symptoms of sexual transmitted infec-
tions. In view of the younger age group considered in the
current study, this item was deemed inappropriate. Age,
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sex, clinic location and HIV test result were collected on
standardized forms.
Data were entered into an ACCESS database using
Cardiff TELEFORM Intelligent Character Optical Mark
Recognition Software (Version 10.7) and analysed using
STATA (Version 12.1). The analysis only included
participants with HIV test results and excluded partici-
pants with missing data for any of the screening items.
Screening items were coded one for positive and zero for
negative responses. The total score was calculated as the
sum of the numerical values of the four screening items
(minimum 0, maximum 4). The maximum screening
score was four and the minimum was zero. x2 and
Student’s t-tests were used to compare categorical data.
Logistic regression was used to investigate the association
between HIV status, individual screening items and
screening scores, with a random effect model and
adjustment using a variance inflation factor to account
for clinic-level clustering [23]. To determine the optimal
cut-off for the screening tool for HIV infection, a receiver
operating characteristic curve (ROC) was plotted. The
area under the ROC curve (AUC) and corresponding
sensitivity, specificity, positive predictive (PPV) and
negative predictive values (NPV), number needed to
test to identify one child living with HIV (NNT), and
reduction in NNT by using the screening tool were
determined for different score levels. Sensitivity and
specificity was also calculated for each of the screening
items separately. A similar analysis was conducted
stratified by age and sex of participants.
The study was approved by Medical Research Council of
Zimbabwe and Ethical Review Committee of The
London School, Hygiene and Tropical Medicine and
Biomedical Research and Training Institute. Consent
procedures for HIV testing of participants followed the
Zimbabwe National Guidelines for HIV Testing and
Counselling and in Children [22].
Results
A total of 12 057 children aged 6 to 15 years were eligible
for PITC, of whom 9655 (80%) underwent HIV testing
(Fig. 1). Of the 9655 participants, 87 were excluded
because they did not respond to all the screening tool
items and/or had some demographic information missing
leaving 9568 for analysis. There was little evidence of a
difference in age and sex between those who underwent
HIV testing and those who did not. However, those who
did not test had a higher proportion of missing answers
(Fig. 1) and lower prevalence of affirmative answers to
each of the screening items and a lower proportion of the
screening tool score (Table 1).
Of the 9568 participants, 4971 (52%) were men, the
median age was 9 years (interquartile, IQR 7–11) and
HIV prevalence was 4.7% (95% confidence interval,
CI:4.2–5.1%) (Table 1). Children aged 6–9 years had a
significantly lower HIV prevalence than those aged not
less than 10 (3.2 vs. 6.4%, P< 0.001). An affirmative
answer to each screening question was associated with
being HIV-positive (Table 1), and the HIV prevalence
increased significantly with an increase in score from 1.4%
among those scoring 0 on the screening tool to 63.6%
among those scoring four (P< 0.001). The sensitivity and
specificity in detecting HIV status varied for the different
screening items, with orphanhood having the highest
HIV screening in children Tsitsi et al. 781
12 057 Eligible for PITC
2402/12 057 (20%) Not tested
- 1066 Child testing declined by guardian/child
- 901 Unsuitable guardian
- 435 Logistical (staff/testing kits/other)
9655/12 057 (80%) Tested
150 (6%) Excluded 
149 did not respond to all questions
1 demographic information missing
87 (1%) Excluded 
83 did not respond to all questions
4 demographic information missing
9568/9655 (99%) included in the
screening Tool Validation  
2252/2402 (94%) included in the
screening Tool Validation
Comparative 
Fig. 1. Selection of the validation study sample.
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sensitivity in predicting HIV infection (53.5%, 95%CI
48.7–58.2%) and poor health having the highest
specificity (93.2%, 95% CI:92.6–93.7%) (Table 2).
Optimal sensitivity and specificity was achieved using a
screening score threshold of not less than one
(AUC¼ 0.73, 95% CI 0.72–0.75) (Fig. 2). Using a
cut-off score of not less than one to screen for HIV testing
had a sensitivity of 80.4% (95%CI 76.5–84.0) and
specificity of 66.3% (95% CI:65.3–67.2%) (Table 2).
Adjustment for clinic-level clustering with variance
adjustment yielded slightly wider confidence intervals
for the specificity only [adjusted sensitivity: 80.4% (95%
CI:77.0–83.9%), specificity: 66.3% (95% CI:58.0–
74.5%)] with no change to the actual estimates. With
an HIV prevalence of 5% in this population, the screening
tool had PPVof 10.4% (95%CI:9.4–11.5%) and aNPVof
98.6% (95% CI:98.3–98.9%). Using a score of not less
than one as the cut-off for the screening tool, the number
needed to test to diagnose one child living with HIV was
10 (95% CI:8.7–10.6), and there would be a 56%
reduction in the number needed to test to diagnose one
child living with HIV if the screening tool was used
compared with universal HIV testing (Table 2). However,
it is also important to note that using the algorithm, an
individual would be falsely classified as ’not at risk’ for
every 70 children screened (Table 2).
The screening items maintained their sensitivity and
specificity and remained strong predictors of HIV
infection after adjustment for clinic-level clustering.
Sex stratified analysis did not yield significant difference in
either sensitivity (83 vs. 79%, P¼ 0.31) or specificity
(66 vs. 67%, P¼ 0.41). However, age-stratified analysis
revealed higher sensitivity of the screening tool among
those aged at least 10 years compared with children aged
6–9 years (84.4 vs. 73.2%, P¼ 0.003), whereas specificity
remained comparable by age group (65.4 vs. 67.0%,
782 AIDS 2016, Vol 30 No 5
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P¼ 0.11). After applying the screening tool the
number needed to test to diagnose one child with
HIV infection was 15 (95% CI:12.6–17.8) in the
6–9 year olds compared with seven (95% CI:6.3–7.9)
in the 10–15 year olds.
Discussion
This study tested the external validity of a simple four
item tool to screen for the risk of HIV infection in older
children and adolescents (aged 6–15 years) in a routine
healthcare setting. The screening tool showed a high
sensitivity and specificity for identifying older children
and adolescents living with HIV attending primary
healthcare facilities. Using this screening tool the number
needed to test to diagnose one child living with HIV
would be reduced from 22 when testing unselectively to
10 when targeted testing is introduced. The screening
tool is designed to identify mainly older children and
adolescents infected through mother-to-child HIV
transmission. Previous paediatric screening tools to
identify children such as the integrated management of
childhood illness/HIV screening tool, have tended to
focus diagnosis of younger children with HIV infection,
are less evidence-based and have had lower sensitivity and
specificity than this screening tool [24–26].
The burden of undiagnosed HIV among older children
remains high and universal access to treatment in children
cannot be achieved without significant scale-up of HIV
testing [18]. However, the much lower prevalence of HIV
infection in this age-group compared with that in adults
means that, in the context of resource constraints blanket
PITC testing strategy may be considered lower priority
and less cost-effective in this age-group [16]. The use of a
simple screening tool to identify those at highest risk
would increase the yield of HIV infection, and reduce the
cost of HIV testing especially amongst an age-group
where the burden of undiagnosed HIV infection is high
but the overall prevalence is low.
The screening tool consists of simple screening items and
can be asked by lay health workers, with minimal training
required. Implementation of the screening tool at scale
might therefore be feasible and may be a sustainable
alternative in the context of constrained resources,
including shortage of staff and testing kits [13,27]. As
well as identifying individuals at high risk of being HIV-
infected, the screening tool may serve to increase
awareness among healthcare providers of the need to
consider HIV infection in older children and adolescents
who do present with the classic HIV disease manifes-
tations. Healthcare workers may be reluctant to discuss
HIV testing with older children and younger adolescents
as this raises uncomfortable questions about the source of
infection [13,28]. The use of a screening tool may prompt
this process in an age-group for whom alternative testing
HIV screening in children Tsitsi et al. 783
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services are often not available. A further advantage could
be normalization of HIV testing for this age-group in
primary care.
The performance of the screening tool, specifically the
NPVand the PPV, depends on the prevalence of HIVand
the prevalence of the factors that constitute the screening
tool. This is context-specific and the prevalence of the
factors will likely change over time. For example, as ART
becomes more widespread, the prevalence of AIDS
orphans may decline. The sensitivity and specificity of the
screening tool may decrease for children attending the
health-facility repeatedly, and performance of the screen-
ing tool will be influenced by whether attendees to
primary care are rescreened on each visit. Whereas
we report data on number of visits rather than on
individuals in this study, participants were not re-screened
or re-tested if they had undergone screening or HIV
testing previously.
Strengths of this study include the large number of
participants resulting in narrow confidence intervals
around sensitivity and specificity estimates. Further, the
data were systematically and prospectively collected over a
prolonged period of time demonstrating sustainability.
The study was conducted in routine healthcare settings
with the screening tool being administered by lay
healthcare workers, making the findings more general-
izable. The limitations are that 20% of eligible primary
care attendees did not undergo testing, and the HIV status
of participants who did not undergo testing was not
available; the prevalence of an affirmative response to the
screening tool items were lower than those among
participants who did undergo HIV testing.
We stress that PITC of all health-facility attendees remains
the optimum strategy and should be implemented
whenever possible. The screening tool will have a false
negativity rate and some children with HIV will be falsely
classified as not at risk. The use of a screening tool offers
an alternative approach taking into account the structural
and other barriers to HIV testing in this age-group.
Ultimately, the goal is to identify and treat children living
with HIV timely and a screening approach provides a
possible pragmatic approach to address some of the
barriers to achieve this goal.
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